Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
Nature reviews. Neuroscience (2008) Vol. 9, Iss. 9, pp. 665-677
Closed Access | Times Cited: 500

Showing 1-25 of 500 citing articles:

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
Timothy R. Sampson, Justine W. Debelius, Taren Thron, et al.
Cell (2016) Vol. 167, Iss. 6, pp. 1469-1480.e12
Open Access | Times Cited: 2924
Direct and indirect pathways of basal ganglia: a critical reappraisal
Paolo Calabresi, Barbara Picconi, Alessandro Tozzi, et al.
Nature Neuroscience (2014) Vol. 17, Iss. 8, pp. 1022-1030
Closed Access | Times Cited: 738
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F. Bastide, Wassilios G. Meissner, Barbara Picconi, et al.
Progress in Neurobiology (2015) Vol. 132, pp. 96-168
Open Access | Times Cited: 428
Basal Ganglia Disorders Associated with Imbalances in the Striatal Striosome and Matrix Compartments
Jill R. Crittenden, Ann M. Graybiel
Frontiers in Neuroanatomy (2011) Vol. 5
Open Access | Times Cited: 398
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
Paolo Calabresi, Massimiliano Di Filippo, Veronica Ghiglieri, et al.
The Lancet Neurology (2010) Vol. 9, Iss. 11, pp. 1106-1117
Closed Access | Times Cited: 358
N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
David Olivares, Varun K. Deshpande, Ying Shi, et al.
Current Alzheimer Research (2012) Vol. 9, Iss. 6, pp. 746-758
Open Access | Times Cited: 349
Diametric neural ensemble dynamics in parkinsonian and dyskinetic states
Jones G. Parker, Jesse D. Marshall, Biafra Ahanonu, et al.
Nature (2018) Vol. 557, Iss. 7704, pp. 177-182
Open Access | Times Cited: 328
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Philippe Huot, Tom H. Johnston, James B. Koprich, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 1, pp. 171-222
Closed Access | Times Cited: 315
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
Roberto Cilia, Albert Akpalu, Fred Stephen Sarfo, et al.
Brain (2014) Vol. 137, Iss. 10, pp. 2731-2742
Open Access | Times Cited: 288
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
Valerie Voon, Pierre‐Olivier Fernagut, Jeffery R. Wickens, et al.
The Lancet Neurology (2009) Vol. 8, Iss. 12, pp. 1140-1149
Closed Access | Times Cited: 288
Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease
Terina N. Martinez, J. Timothy Greenamyre
Antioxidants and Redox Signaling (2011) Vol. 16, Iss. 9, pp. 920-934
Open Access | Times Cited: 244
Clinical spectrum of levodopa‐induced complications
Camila C. Aquino, Susan H. Fox
Movement Disorders (2014) Vol. 30, Iss. 1, pp. 80-89
Closed Access | Times Cited: 239
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Giuseppe Tardiolo, Placido Bramanti, Emanuela Mazzon
Molecules (2018) Vol. 23, Iss. 12, pp. 3305-3305
Open Access | Times Cited: 237
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
Weixing Shen, Joshua L. Plotkin, Veronica Francardo, et al.
Neuron (2015) Vol. 88, Iss. 4, pp. 762-773
Open Access | Times Cited: 218
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols, P. Jeffrey Conn
Neurobiology of Disease (2013) Vol. 61, pp. 55-71
Open Access | Times Cited: 216
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
M. Angela Cenci
Frontiers in Neurology (2014) Vol. 5
Open Access | Times Cited: 202
Gut microbiota and aging
Zongxin Ling, Xia Liu, Yiwen Cheng, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 13, pp. 3509-3534
Closed Access | Times Cited: 172
Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
Destany K. Kwon, Mohit Kwatra, Jing Wang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3736-3736
Open Access | Times Cited: 78
Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA–Induced Dyskinesia and Histone Activation
Sanja Darmopil, Ana Belén Martín, Irene Ruiz‐DeDiego, et al.
Biological Psychiatry (2009) Vol. 66, Iss. 6, pp. 603-613
Closed Access | Times Cited: 259
Maladaptive striatal plasticity in l-DOPA-induced dyskinesia
M. Angela Cenci, Christine Konradi
Progress in brain research (2010), pp. 209-233
Open Access | Times Cited: 196
Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors
Anthony J. Anzalone, José Lizardi-Ortiz, Milagros Ramos, et al.
Journal of Neuroscience (2012) Vol. 32, Iss. 26, pp. 9023-9034
Open Access | Times Cited: 191
The anatomical basis of dystonia: Current view using neuroimaging
Stéphane Lehéricy, Marina A.J. Tijssen, Marie Vidailhet, et al.
Movement Disorders (2013) Vol. 28, Iss. 7, pp. 944-957
Closed Access | Times Cited: 184
Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells
Xinjian Liu, Li Fang, Elizabeth A. Stubblefield, et al.
Cell Research (2011) Vol. 22, Iss. 2, pp. 321-332
Open Access | Times Cited: 183
The serotonergic system in Parkinson's disease
Philippe Huot, Susan H. Fox, Jonathan M. Brotchie
Progress in Neurobiology (2011) Vol. 95, Iss. 2, pp. 163-212
Closed Access | Times Cited: 182
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
Maryka Quik, Susan Wonnacott
Pharmacological Reviews (2011) Vol. 63, Iss. 4, pp. 938-966
Open Access | Times Cited: 177
Page 1 - Next Page

Scroll to top